Duc H T, Kinsky R G, Kanellopoulos J, Voisin G A
J Immunol. 1975 Oct;115(4):1143-50.
The influence of the course of immunization on the facilitating-enhancing activity of antibody classes has been studied by passive enhancement of growth of A/JAX sarcomas in CBA and IC mice and of C57BL/6 EL 4 leukemia in BALB/c mice. The influence of dilution of antibodies and complexing to antigens was also studied. During immunization (with several boosters), the enhancing capacity of sera increased together with 7S IgG antibody activity, but showed no correlation with 19S IgM antibody activity. It also was mercaptoethanol resistant. IgG1 to be more enhancing than an equal number of hemagglutinating units of IgG2a. When concentrated on a small amount (10(5)) of target sarcoma I cells, complement-fixing IC anti-A antibodies were even inhibitory on Sa I allografted to IC recipients. Progressive dilutions reversed this situation, IgG1 activity disappearing and IgG2 acquiring enhancing activity. After complexing to corresponding antigens IgG2 also (and immune sera with inhibitory properties) acquired enhancing properties. These results may provide a basis for understanding the discrepancies between the results of several groups of authors studying the class(es) of enhancing anibodies.
通过被动增强 A/JAX 肉瘤在 CBA 和 IC 小鼠中的生长以及 C57BL/6 EL 4 白血病在 BALB/c 小鼠中的生长,研究了免疫过程对抗体类别促进增强活性的影响。还研究了抗体稀释以及与抗原复合的影响。在免疫过程中(多次加强免疫),血清的增强能力随着 7S IgG 抗体活性的增加而增加,但与 19S IgM 抗体活性无关。它对巯基乙醇也具有抗性。IgG1 比等量的 IgG2a 血凝单位更具增强作用。当集中在少量(10(5))靶肉瘤 I 细胞上时,补体结合的 IC 抗 A 抗体对移植到 IC 受体的 Sa I 甚至具有抑制作用。逐步稀释可逆转这种情况,IgG1 活性消失,IgG2 获得增强活性。与相应抗原复合后,IgG2 也(以及具有抑制特性的免疫血清)获得了增强特性。这些结果可能为理解几组研究增强抗体类别的作者的结果之间的差异提供基础。